GLIOBLASTOMA
Clinical trials for GLIOBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new GLIOBLASTOMA trials appear
Sign up with your email to follow new studies for GLIOBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental brain tumor combo shows promise in early trial
Disease control TerminatedThis study tested an experimental drug called zotiraciclib (TG02) combined with the standard chemotherapy temozolomide in adults with recurrent anaplastic astrocytoma or glioblastoma. The goal was to find safe doses and see if the combination works better than temozolomide alone.…
Matched conditions: GLIOBLASTOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 30, 2026 15:50 UTC
-
CBD anxiety trial for brain cancer patients ends early
Symptom relief TerminatedThis study aimed to see if a high-CBD hemp product could reduce anxiety and improve quality of life in people newly diagnosed with glioblastoma, a serious brain tumor. The trial planned to compare the CBD product to a placebo over 8 weeks, but it was stopped early and only enroll…
Matched conditions: GLIOBLASTOMA
Phase: PHASE2 • Sponsor: Mclean Hospital • Aim: Symptom relief
Last updated Apr 30, 2026 15:50 UTC
-
Brain tumor molecule study halted early
Knowledge-focused TerminatedThis study looked at a molecule called microRNA-10b in people with gliomas, a type of brain tumor. Researchers wanted to see if levels of this molecule could help predict how long patients live or how their tumor behaves. They collected tumor, blood, and spinal fluid samples from…
Matched conditions: GLIOBLASTOMA
Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Knowledge-focused
Last updated May 01, 2026 15:27 UTC
-
Brain cancer drug penetration study halted early
Knowledge-focused TerminatedThis early-stage study aimed to see how much of the drug infigratinib gets into brain tumors in people with recurrent high-grade glioma (a fast-growing brain cancer). Only 7 participants were enrolled before the study was stopped. Researchers measured drug levels in tumor tissue,…
Matched conditions: GLIOBLASTOMA
Phase: EARLY_PHASE1 • Sponsor: Nader Sanai • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:51 UTC